Featured News

March 20th, 2019

Takeda and HemoShear Therapeutics Extend Exclusive Drug Discovery Partnership in Liver Diseases

Read More »
March 6th, 2019

HemoShear Therapeutics Physiological Human Tumor Model Published in Lab on a Chip Journal

Read More »
January 3rd, 2019

Horizon Pharma Plc and HemoShear Therapeutics Enter Into Exclusive Drug Discovery Collaboration in Gout

Read More »
December 4th, 2018

Carnot Biosciences, A Spin Off Of Smartzyme Biopharma, And Hemoshear Therapeutics Partner To Develope Protein-Based Therapeutics For Rare Metabolic Diseases

Read More »
November 9th, 2018

Shear Insights: HemoShear Identifies Novel Targets for Treating Liver Diseases

Read More »
May 4th, 2018

Q&A with Brian Wamhoff, PhD, Head of Innovation, HemoShear Therapeutics

View on Rare Disease Report
October 17th, 2017

Takeda and HemoShear Therapeutics Enter Into Exclusive Drug Discovery Partnership in Liver Diseases

Read More »

Contact

info@hemoshear.com

501 Locust Avenue
Suite 301
Charlottesville, Virginia 22902